224 related articles for article (PubMed ID: 32511945)
1. Risk of surgical evacuation and risk of major surgery following second-trimester medical abortion in Denmark: A nationwide cohort study.
Meaidi A; Jasmin Friedrich S; Lidegaard Ø
Contraception; 2020 Sep; 102(3):201-206. PubMed ID: 32511945
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for surgical intervention of early medical abortion.
Meaidi A; Friedrich S; Gerds TA; Lidegaard O
Am J Obstet Gynecol; 2019 May; 220(5):478.e1-478.e15. PubMed ID: 30763542
[TBL] [Abstract][Full Text] [Related]
3. Complication rates of dilation and evacuation and labor induction in second-trimester abortion for fetal indications: A retrospective cohort study.
Jacques L; Heinlein M; Ralph J; Pan A; Nugent M; Kaljo K; Farez R
Contraception; 2020 Aug; 102(2):83-86. PubMed ID: 32360665
[TBL] [Abstract][Full Text] [Related]
4. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
[TBL] [Abstract][Full Text] [Related]
5. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
Reeves MF; Monmaney JA; Creinin MD
Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
[TBL] [Abstract][Full Text] [Related]
6. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of surgical evacuation following second-trimester medical termination of pregnancy.
Mentula M; Heikinheimo O
Contraception; 2012 Aug; 86(2):141-6. PubMed ID: 22240172
[TBL] [Abstract][Full Text] [Related]
8. Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia.
Louie KS; Chong E; Tsereteli T; Avagyan G; Abrahamyan R; Winikoff B
Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):76-80. PubMed ID: 27871191
[TBL] [Abstract][Full Text] [Related]
9. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
[TBL] [Abstract][Full Text] [Related]
10. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
Mentula M; Suhonen S; Heikinheimo O
Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
[TBL] [Abstract][Full Text] [Related]
12. Medical Induction for Mid trimester Abortion: A Hospital-based Descriptive Cross-sectional Study.
Sharma J; Tiwari S; Pokhrel M; Lama L
JNMA J Nepal Med Assoc; 2020 Oct; 58(230):794-797. PubMed ID: 34504357
[TBL] [Abstract][Full Text] [Related]
13. Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
Dickinson JE; Doherty DA
Contraception; 2023 Sep; 125():110080. PubMed ID: 37245784
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
[TBL] [Abstract][Full Text] [Related]
15. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial.
Ngoc NTN; Shochet T; Raghavan S; Blum J; Nga NTB; Minh NTH; Phan VQ; Winikoff B
Obstet Gynecol; 2011 Sep; 118(3):601-608. PubMed ID: 21860289
[TBL] [Abstract][Full Text] [Related]
17. First trimester abortion with mifepristone and vaginal misoprostol.
Knudsen UB
Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review.
Dodd JM; Crowther CA
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):3-8. PubMed ID: 16466671
[TBL] [Abstract][Full Text] [Related]
19. A comparison of medical induction and dilation and evacuation for second-trimester abortion.
Autry AM; Hayes EC; Jacobson GF; Kirby RS
Am J Obstet Gynecol; 2002 Aug; 187(2):393-7. PubMed ID: 12193931
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
